Skip to content

Author

C. Bettegowda

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

A novel approach to reverse Warburg metabolism in patients with recurrent glioblastoma: A phase II pharmacodynamic study of dichloroacetate

Abstract Background Glioblastomas are characterized by the Warburg effect, driven by upregulation of pyruvate dehydrogenase kinase (PDK), which inhibits pyruvate dehydrogenase complex (PDC), leading to lactate accumulation. Dichloroacetate (DCA) is a potent and safe PDK inhibitor that crosses the blood-brain barrier, r...

Carolyn O. Dirain, Stuart A. Grossman, Xiao-Bu Ye et al. · 1 citation
Open access Aug 2026

SADA-14 WHEN COMPLICATIONS MATTER: THE IMPACT OF POSTOPERATIVE ADVERSE EVENTS ON SURVIVAL AND QUALITY OF LIFE IN METASTATIC SPINE DISEASE

Postoperative AE’s are extremely relevant to the care of patients with MSD and impact both HRQoL and survival and a multivariate analysis demonstrated that age, smoking status, ECOG performance, prior radiotherapy, presence of multiple metastases at other sites, and multiple spine metastases were significant risk facto...

Andrew A. Hardigan, G. B. Brodano, Christina Griffoni et al. · 0 citations
Open access Aug 2026

SADA-13 TOWARD CONSENSUS: DEFINING OPTIMAL SURGICAL OUTCOMES IN METASTATIC SPINE DISEASE

This is the first study defining a composite measure outcome in oncologic surgery for spinal metastases derived from an international group of surgeons and oncologists who treat patients for MSD and the OSCO-M will be useful for defining clinical success in patients undergoing treatment for MSD.

Andrew A. Hardigan, R. de la Garza Ramos, Michael H. Weber et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.